Objective. The development of obesity and its metabolic complications is associated with dysregulation of various intrinsic mechanisms, which control basic metabolic processes via changes in the expression of numerous regulatory genes. The main goal of this work was to study the association between the expression of insulin-like growth factors (IGF1 and IGF2) and IGF-binding proteins and insulin resistance in obese adolescents for evaluation of possible contribution of these genes in development of insulin resistance.
ronmental factors and is associated with changes in gene expressions of regulatory network in various organs and tissues, but preferentially in adipose tissue (Shimba et al. 2011; Wang and Kaufman 2012; Han and Kaufman 2016; Mao and Zhang 2018) . Adipose tissue growth is in a center of the obesity and is tightly associated with the glucose and lipid metabolism as well as cell proliferation processes. It is controlled by different interconnected regulatory factors and enzymes (Ozcan et al. 2004; Lee and Ozcan 2014) . At the same time, the blood reflects numerous changes in different organs and tissues in diseases including obesity (Ando et al. 2011) . Special interest deserves the key regulatory enzymes and factors, which control glucose and lipid metabolism as well as cell growth (Ruderman et al. 2013; Hassler et al. 2015; Han and Kaufman 2016; Tiaden et al. 2016; Ghoshal et al. 2018) .
Receptors of insulin-like growth factor (IGF) and insulin as well as related proteins play an important role in the regulation of numerous metabolic and proliferative processes and participate in endoplasmic reticulum stress, which is an important factor of tumor growth, insulin resistance, and obesity (Pollak 2012; Kuijjer et al. 2013; Yuzefovych et al. 2013; Han and Kaufman 2014; Lee and Ozcan 2014) . Furthermore, there exists a cross talk between IGF and insulin receptor signaling pathways at the receptor level or downstream signaling level. This cross talk significantly changed the IGF/insulin receptor isoforms in a variety of cancers. Overexpression and formation of hybrid receptor isoforms between IGF1 receptor and insulin receptor, which are sensitive to the stimulation of all three IGF axis ligands, as well as hybrid receptors of IGF1 receptor and insulin receptor with other tyrosine kinases, potentiate the cellular transformation, tumorigenesis, and tumor vascularization (Kuijjer et al. 2013) .
The insulin-like growth factor binding proteins (IGFBPs) bind and regulate the availability of both IGFs, prolong the half-life of the IGFs, and inhibit or stimulate the growth promoting effects of the IGFs through IGF/INS receptors. Now, they are understood to have many actions beyond their endocrine role in IGF transport (Foulstone et al. 2013; Liu et al. 2014; Maridas et al. 2017; Cai et al. 2018) . Moreover, IGFBP2 not only modulates IGFs but also directly regulates PTEN and has a role in the maintaining of the estrogen receptor-alpha expression and plays an important role in the tumorigenesis promotion (Foulstone et al. 2013; Ahani et al. 2014; Li et al. 2017) . Additionally, IGFBP2 is increased the expression of p-p65 and nuclear p65, while IGFBP2 knockdown reduced the NF-κB signaling pathway (Yuan et al. 2017) . It is interesting to note that both IGFBP1 and IGFBP2 are linked to insulin resistance, obesity, the type 2 diabetes, and metabolic syndrome, because they are at the interface of growth and metabolism (Sabin et al. 2011; Gokulakrishnan et al. 2012; Kim and Lee 2015) .
IGFBP4 preferentially binds to IGF2 and regulates growth and development of tissues and organs by negatively regulating IGF signaling. It has also IGF-independent effects including inhibition of angiogenesis and promotion of cancer cell migration (Praveen Kumar et al. 2014) . This IGF binding protein is required for adipogenesis and influences the distribution of adipose depots (Maridas et al. 2017) . The IGFBP5, which is often dysregulated in human cancers, plays a crucial role in the carcinogenesis and cancer development, preferentially acts as an important tumor suppressor, and the proliferation of IGFBP5-mutated cancer cells is selectively blocked by IGF1R inhibitors Ding et al. 2016; Neuzillet et al. 2017) .
The HTRA1/PRSS11 gene encoded serine protease with IGF-binding domain, which functioning as important modulators of many physiological processes, including cell signaling and apoptosis, regulates the availability of IGFs by cleaving IGFBPs and has a pivotal role in both cell proliferation and differentiation (D'Angelo et al. 2014; Zurawa-Janicka et al. 2017; Schillinger et al. 2018) . Recently, it has been shown that lysyl oxidase regulates the epidermal growth factor receptor to facilitate its activation by EGF to drive tumor progression by suppressing TGFβ1 signaling through the secreted protease HTRA1 (Tang et al. 2017) . There are data indicating that HTRA1, as a negative regulator of mesenchymal stem cells adipogenesis, participates in the adipose tissue remodeling under pathological conditions (Tiaden et al. 2016) .
Many different factors affecting the homeostasis have been shown to induce a complex of intracellular signaling events in the endoplasmic reticulum, which is known as the unfolded protein response/endoplasmic reticulum stress Minchenko et al. 2014; Lee and Ozcan 2014; Manie et al. 2014) . It participates in the early cellular response to the accumulation of misfolded proteins in the lumen of the endoplasmic reticulum, which is a dynamic intracellular organelle with exquisite sensitivity to alterations in homeostasis, and provides stringent quality control systems to ensure that only correctly folded proteins transit to the Golgi apparatus and unfolded or misfolded proteins are retained and ultimately degraded (Ferris et al. 2014; Doultsinos et al. 2017) . Activation of the endoplasmic reticulum stress sensors leads to the transcriptional reprogramming of the cells (Chevet et al. 2015) . Moreover, inhibition of IRE1 mediated signaling pathway of endoplasmic reticulum stress affects the expression of proliferation-related and many other genes including insulin-like growth factor binding protein genes (Auf et al. 2013; Minchenko et al. 2015a,b; Minchenko et al. 2016) . The endoplasmic reticulum stress is recognized as an important determinant of cancer, obesity and type 2 diabetes and contributes to the expression profile of many regulatory genes resulting in proliferation, apoptosis, and peripheral insulin resistance (Ozcan et al. 2004; Han and Kaufman 2014; Lee and Ozcan 2014; Manie et al. 2014; Chevet et al. 2015) , although detailed molecular mechanisms cannot be ruled out.
It is possible that identification of real mechanisms of metabolic abnormalities in obesity as well as its complications at molecular and cellular levels helps to better understand why the obesity develops and why only a part of the obese individuals develops secondary metabolic disorders. However, a detailed molecular mechanism of the involvement of different genes of regulatory network in the development of obesity and its complications are not clear yet and remains to be determined.
The main goal of this study was to clarify the role of the expression of a subset of genes, encoding for important cell growth (IGFs) and IGFBPs, in blood of obese adolescents for evaluation of its possible significance for the development of obesity and insulin resistance.
Materials and methods
Patients' clinical characteristics. The 21 male adolescents participate in this study. They were divided into three equal groups (7 subjects in each group): one group of normal individuals as control and two groups of obese patients: with or without insulin resistance. All participants gave written informed consent and the studies were approved by the local research ethics committees of Institute of Children and Adolescent Health Care of the National Academy of Medical Science of Ukraine.
Clinical characteristics of the study participants are shown in Table 1 . The normal (control) participants were individuals with mean age 14.2±0.584 years and mean body mass index (BMI) 18.8±0.17 kg/m 2 . The obese participants with normal insulin sensitivity as well as the patients with insulin resistance were individuals with mean age (13.8±0.265 and 14.5±0.297 years, respectively) and mean BMI (31.1±0.36 and 34.3±1.72 kg/m 2 , correspondingly). Thus, BMI, which is a main criterion of obesity, in these last two groups of patients was significantly higher (+65 and +82%, respectively; p<0.01 in both cases) as compared to control individuals (Table 1) . Moreover, no significant changes were found in insulin resistance index (HOMA) in obese individuals as compared to control group, but in obese patients with impaired insulin sensitivity, versus control boys as well as obese subjects with normal insulin sensitivity the insulin resistance index is significantly increased (3.6-and 3.2-fold, respectively; p<0.001 in both cases) ( Table 1) . Similar results were observed in the fasting insulin levels: no significant changes in obese individuals and strong increase in obese adolescents with insulin resistance (3.3.-fold, p<0.001, as compared to control group and 3-fold, p<0.001, as compared to obese adolescents without insulin resistance) as compared to control group. At the same time, both obesity and obesity with insulin resistance did not change significantly the level of fasting glucose, since 2 h oral glucose tolerance test (OGTT) was significantly higher (+29%, respectively; p<0.05), but only in the group of obese adolescents with insulin resistance as compared to control individuals (Table 1) . RNA isolation. Trisol reagent (Invitrogen, USA) was used for RNA extraction from blood of normal (control) and obese individuals with or without insulin resistance as described previously (Auf et al. 2013 ). The RNA pellets were washed with 75% ethanol and dissolved in nuclease-free water. For additional purification RNA samples were re-precipitated with 95% ethanol and re-dissolved in nuclease-free water. RNA concentration as well as spectral characteristics was measured using NanoDrop Spectrophotometer ND1000 (PEQLAB, Biotechnologie GmbH).
Reverse transcription and quantitative real-time polymerase chain reaction analysis. Thermo Scientific Verso cDNA Synthesis Kit was used for reverse transcription. The expression level of IGF1, IGF2, IGFBP2, IGFBP4, IGFBP5, IGFBP7, and HTRA1 genes were measured in RNA samples from blood by realtime quantitative polymerase chain reaction of complementary DNA (cDNA). The "QuantStudio 5 RealTime PCR System" (Applied Biosystems), Absolute QPCR SYBRGreen Mix (Thermo Scientific, UK) and pair of primers specific for each studied gene (Sigma/ Aldrich, USA) was used for quantitative polymerase chain reaction (Table 2) .
The expression of beta-actin mRNA was used as control of analyzed RNA quantity. The amplified DNA fragments were analyzed on a 2% agarose gel and that visualized by 5x Sight DNA Stain (EURO-MEDEA). An analysis of quantitative PCR was performed using special computer program "Differential expression calculator". Statistical analyses were performed according to Student's t-test using OriginPro 7.5 software. All values are expressed as mean ± SEM from seven independent experiments; p<0.05 was considered as significant difference.
Results
We analyzed the expression of a subset of genes encoding IGF1, IGF2, IGFBP2, IGFBP4, IGFBP5, IGFBP7, and HTRA1, which are associated with cell proliferation, glucose and lipid metabolism, in blood cells of three groups: normal (control) adolescents, obese boys with normal insulin sensitivity, and obese individuals with insulin resistance using quantitative polymerase chain reaction. As shown in Figure 1 , the expression level of IGF1 and IGF2 genes in the blood of obese adolescents with normal sensitivity to insulin did not change significantly (Figures 1 and 2 ). At the same time, the expression level of IGF1 gene is significantly decreased (-30%; p<0.05) in obese adolescents with insulin resistance as compared to control group (Figure 1) . Moreover, the similar changes in the expression level of IGF1 gene were also observed in the blood of obese individuals with insulin resistance as compared to the group of obese adolescents without insulin resistance (-32%; p<0.05). We have also shown that the development of insulin resistance in obese individuals leads to up-regulation of the expression level of IGF2 gene in the blood: +12% (p<0.05) as compared to control group and +15% (p<0.05) as compared to the group of obese individuals with normal sensitivity to insulin (Figure 2) .
We also found that development of obesity with normal sensitivity to insulin leads to up-regulation of the expression of IGF binding protein 2 in the blood (+43%; p<0.01) as compared to control group of adolescents (Figure 3 ). More strong changes in this gene expression were observed in obese individuals with impaired sensitivity to insulin: +75 % (p<0.01) as compared to control group and +22% (p<0.05) as compared to the group of obese individuals with normal sensitivity to insulin ( Figure 3 ). As shown in Figure 4 , the expression of IGFBP4, which is a non-classical IGFBP molecule with an important IGF-independent effect including inhibition of angiogenesis and control of adipogenesis as well as the distribution of adipose depots, is down-regulated in the blood of both group of obese adolescents (with normal sensitivity to insulin and insulin resistance): -31 and -35%, respectively; p<0.05 in both cases. Thus, the development of insulin resistance in obese adolescents does not change significantly the expression level of this IGF binding protein.
The expression level of IGFBP5 mRNA is also decreased in obese adolescents with normal sensitivity to insulin as compared to control cells (-22%, Figure 5 ). Therefore, the development of insulin resistance in obese individuals led to more prominent changes in IGFBP5 mRNA expression: -47% (p<0.01) as compared to control group and -24% (p<0.05) as compared to the group of obese adolescents with normal sensitivity to insulin ( Figure 5 ). It is possible that changes in the expression of IGFBP5, which preferentially acts as an important tumor suppressor, can contribute to the development of obesity and insulin resistance as well as other obesity complications.
Next, we investigated the expression level of IGFBP7 mRNA in the blood of obese adolescents with normal sensitivity to insulin and insulin resistance. As shown in Figure 6 , the expression level of IGFBP7 significantly increases in the group of obese individuals with normal sensitivity to insulin (+76%; p<0.01) as compared to control group of adolescents ( Figure  6 ). More strong changes in this gene expression were observed in obese individuals with impaired sensitivity to insulin: +148% (p<0.001) as compared to control group and +41% (p<0.01) as compared to the group of obese individuals with normal sensitivity to insulin (Figure 6 ). We have also studied the expression level of hightemperature requirement A serine peptidase 1, which is a stress responsible enzyme and also known as a serine protease with IGF-binding domain PRSS11. As shown in Figure 7 , this mRNA expression is decreased in the blood of obese adolescents with normal sensitivity to insulin (-14%; p<0.05). Therefore, development of insulin resistance leads to more prominent changes in HTRA1 mRNA expression: -30% (p<0.05) as compared to control group and -19% (p<0.05) as compared to the group of obese adolescents with normal sensitivity to insulin (Figure 7 ).
Discussion
Results of this investigation clearly demonstrate that obesity alters the expression level of all studied IGF binding protein genes in gene-specific manner in the blood and that these changes preferentially are insulin sensitive (Figure 8 ). Thus, the expression level of IGFBP2 and IGFBP7 genes is increased, but -IGFBP4, IGFBP5, and HTRA1 genes is decreased in obese individuals with normal sensitivity to insulin. Similar, but more prominent changes were shown for all these genes, except IGFBP4, in obese adolescents with insulin resistance. At the same time, the expression level of IGF1 and IGF2 did not change significantly in obese individuals with normal sensitivity to insulin, but biological activity of both these growth factors possibly is affected in obesity with normal sensitivity to insulin because significant changes were observed in different IGF binding proteins, which bind and regulate the availability of both IGFs, their half-life and inhibit or stimulate the growth promoting effects of the IGFs through IGF/INS receptors (Baxter 2014) . However, development of insulin resistance affects the expression of both IGF genes: decreases IGF1 and increases IGF2 (Figure 8) .
The development of obesity as well as its metabolic complications is associated with dysregulation of numerous intrinsic mechanisms, which control most key metabolic processes, including cellular growth, glucose, and lipid metabolism as well as insulin sensitivity (Ruderman et al. 2013; Martin et al. 2015; Tam et al. 2017; Ghoshal et al. 2018; Mao and Zhang 2018) . It is possible that changes in IGFs and IGFBPs, which we observed in childhood obesity with and without insulin resistance, can contribute to these numerous intrinsic mechanisms of glucose and lipid metabolism dysregulation as well as cellular growth, because insulin-like growth factors and related proteins play an important role in the regulation of numerous metabolic and proliferative processes and participate in endoplasmic reticulum stress, an important factor of insulin resistance and obesity (Pollak 2012; Kuijjer et al. 2013; Yuzefovych et al. 2013; Han and Kaufman 2014; Lee and Ozcan 2014; Sunderic et al. 2014) . Furthermore, there exists a cross talk between IGFs and insulin receptor signaling pathways at the receptor level or downstream signaling level (Kuijjer et al. 2013) . It is interesting to note that insulin/IGFs can regulate a long non-coding RNA CRNDE, which control genes involved in central metabolism (Ellis et al. 2014) . Recently, Sun et al. (2018) demonstrate that both INSR and IGF1R are directly targeted by C-myc and exert similar effects to promote the tumorigenesis and metastasis of TSCC through the NF-kappa B pathway. Moreover, insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation (Kuffer et al. 2018) . Disruption of this gene alters hepatic lipid homeostasis and gene expression in the newborn mouse (Lopez et al. 2018) .
The insulin-like growth factor binding proteins bind and regulate the availability of both IGFs, prolong the half-life of the IGFs, and inhibit or stimulate the growth promoting effects of the IGFs through IGF/INS receptors. They are now understood to have many actions beyond their endocrine role in IGF transport (Foulstone et al. 2013; Liu et al. 2014; Maridas et al. 2017; Cai et al. 2018) . There is now substantial evidence linking IGFBP-2 with nutritional status and insulin sensitivity (Sabin et al. 2011) . IGFBPs are also functioning in the pericellular and intracellular compartments to regulate cell growth and survival (Holmes et al. 2012) . Because they interact with many proteins, IGF1 and IGF2, in addition to their canonical ligands, also play an intranuclear role in the regulation of transcription (Baxter 2014; Praveen Kumar et al. 2014) .
Taking into account the importance of IGFBPs function, we suggest that obesity-mediated down-regulation of IGFBP4 and IGFBP5 as well as up-regulation of IGFBP2 and IGFBP7 gene expressions , IGF2, IGFBP2, IGFBP4, IGFBP5, IGFBP7 , and HTRA1 genes expression profile the blood of obese adolescences with normal insulin sensitivity and insulin resistance as compared to control group. NC -no significant changes. may contribute to the dysregulation of glucose and lipid metabolism. Moreover, our results clearly indicate that obesity is a risk factor for tumorigenesis, because IGFBP2 not only modulates IGFs but also directly regulates PTEN, has a role in the maintaining of the estrogen receptor-alpha expression and plays an important role in promoting tumorigenesis, through estrogen and estrogen receptor-alpha signaling pathway (Foulstone et al. 2013; Huang et al. 2017; Li et al. 2017) . Recently, it has been shown that exogenous IGFBP2 promotes proliferation and invasion in glioma cells via the integrin β1-ERK pathway and that this IGFBP with MDA9/syntenin promotes angiogenesis in human melanoma . Ord et al. (2015) have shown that cell viability during glucose deprivation is enhances by TRIB3 (pseudokinase Tribbles homolog 3) through upregulation of IGFBP2, which is recognized as a novel nutrient deficiency survival factor. Furthermore, IGFBP2 is a direct and functional downstream target of microR-NA-592, which is involved in the microRNA-592-mediated tumor-suppressive effects in glioma cells (Peng et al. 2017) . It is interesting to note that both IGFBP1 and IGFBP2 are linked to insulin resistance, obesity, and the type 2 diabetes mellitus, and metabolic syndrome, because they are at the interface of growth and metabolism (Sabin et al. 2011; Gokulakrishnan et al. 2012; Kim and Lee 2015) . High level of IGFPB7 expression in obese individuals can also play a role in promoting tumorigenesis, because there is data that the low levels of IGFPB7 in high-grade serous ovarian carcinoma relative to normal tissues, and association with survival are consistent with a purported role in tumor suppressor pathways (Liu et al. 2014; Gambaro et al. 2015) .
In this study we showed that obesity down-regulates the expression of both IGFBP4 and IGFBP5, which was preferentially shown with tumor suppressor properties by negatively regulating IGF signaling as well as through IGF-independent effects including inhibition of angiogenesis and promotion of cancer cell migration (Praveen Kumar et al. 2014) . Our results are consistent with the data of Hermani et al. (2013) that IGFBP4 modulates ligand-dependent estrogen receptor-alpha activation in breast cancer cells in an IGF-independent manner through activation of the Akt/PKB signaling pathway as well as to data Contois et al. (2015) , that inhibition of tumor-associated αvβ3 integrin regulates the angiogenic switch by enhancing the expression of IGFBP4, as important negative regulator of IGF-1 signaling, leading to reduced melanoma growth and angiogenesis in vivo. It is useful to note that in the upstream region of IGFBP4 gene is located lncRNA (lnc-IGFBP4-1), which is significantly up-regulated in lung cancer tissues and plays a positive role in cell proliferation and metastasis through possible mechanism of reprogramming tumor cell energy metabolism (Yang et al. 2017) . The IGFBP5, which is often dysregulated in human cancers, plays a crucial role in the carcinogenesis and cancer development, preferentially acts as an important tumor suppressor and the proliferation of IGFBP5-mutated cancer cells is selectively blocked by IGF1R inhibitors Ding et al. 2016; Neuzillet et al. 2017) . Furthermore, overexpression of IGFBP5 suppresses epithelial-mesenchymal transition and decreases the expression of E-cadherin, exerts its inhibitory activities by reducing the phosphorylation of IGF1R, ERK1/2, and p38-MAPK kinases and abating the expression of HIF1α and its target genes, VEGF and MMP9 Hwang et al. 2016) . These data completely agree with our results, which demonstrated possible mechanism connecting obesity with tumorigenesis as well as with data of Tsuchihara et al. (2008) .
We also showed that obesity down-regulates the expression of HTRA1 gene encoded serine protease with IGF-binding domain, which functions as important modulators of many physiological processes, including cell signaling and apoptosis, regulates the availability of IGFs by cleaving IGFBPs and has a pivotal role in both cell proliferation and differentiation (D'Angelo et al. 2014; Zurawa-Janicka et al. 2017; Schillinger et al. 2018) . Our results concerning the obesity related changes in HTRA1 expression agree with data of Tiaden et al. (2016) that this enzyme, as a negative regulator of mesenchymal stem cells adipogenesis, participates in the adipose tissue remodeling under pathological conditions. It is also useful to note that highly conserved serine protease HTRA1 also degrades amyloid fibrils in an ATP-independent manner (Poepsel et al. 2015) . It solubilizes protein fibrils and disintegrates the fibrillary core structure, allowing productive interaction of aggregated polypeptides with the active site for rapid degradation. It has also been shown that brain injury induces HTRA1 expression in reactive astrocytes, and loss of HTRA1 leads to an impairment in wound closure accompanied by increased proliferation of endothelial and immune cells (Chen et al. 2018) . It is possible that obesity and insulin resistance related down-regulation of HTRA1 participates in the development of some obesity complications.
Previously, it has been shown that IGF1, IGF2, and all studied IGFBPs are responsible from endoplasmic reticulum stress, which is recognized as an important determinant of obesity and type 2 diabetes and contributes to the expression profile of many regulatory genes resulting in proliferation, apoptosis, and peripheral insulin resistance (Han and Kaufman 2014; Lee and Ozcan 2014; Manie et al. 2014; Chevet et al. 2015; Minchenko et al. 2015a Minchenko et al. , 2016 . Therefore, it is possible that most obesity and insulin related changes in the expression of IGFs and IGFBPs genes are mediated through endoplasmic reticulum stress, although detailed molecular mechanisms cannot be ruled out.
It is possible that identification of real mechanisms of metabolic abnormalities in obesity as well as its complications at molecular and cellular levels leads to a better understanding why obesity develops and why only a part of the obese individuals develops secondary metabolic disorders. However, a detailed molecular mechanism of the involvement of different genes of regulatory network in the development of obesity and its complications are not clear yet and remains to be determined.
